EEG biomarkers can predict early-stage Alzheimer's disease and correlate with intracerebral pathology: a multimodal machine learning study.
Source check: Source checked. Not independent scientific confirmation.
Finding: Resting-state EEG features and ML distinguish early Alzheimer disease from healthy controls; test-set multimodal PSD/microstate AUC is reported alongside correlations with intracerebral pathology/cognition. The result is cohort-specific. The result is reported in the Alzheimer's Research & Therapy. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: Resting-state EEG features and ML distinguish early Alzheimer disease from healthy controls
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Resting-state EEG features and ML distinguish early Alzheimer disease from healthy controls
- Test and result
- Resting-state EEG features and ML distinguish early Alzheimer disease from healthy controls; test-set multimodal PSD/microstate AUC is reported alongside correlations with intracerebral pathology/cognition. The result is cohort-specific.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13425775/ · https://doi.org/10.1186/s13195-026-02096-3 · https://europepmc.org/article/MED/42216097
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.